NCT06657807Active, not recruiting
Online Cognitive Behavior Therapy for Anxiety Related to Pediatric Asthma
Online Cognitive Behavior Therapy for Anxiety Related to Pediatric Asthma: A Feasibility Study
Source: ClinicalTrials.gov · Last updated 14 May 2026
Brief summary (registry, in English)
Asthma is a chronic condition affecting approximately 5-15% of all Swedish children. Research has shown that asthma may be associated with increased anxiety and worry, with children who have asthma being twice as likely to experience anxiety compared to those without asthma. The coexistence of anxiety and asthma can worsen asthma symptoms and heighten anxiety, as it can be challenging to distinguish between the two conditions. Cognitive behavioral therapy (CBT) is a recommended treatment for anxiety in children, but few studies have examined the effectiveness of CBT in children with both asthma and anxiety. Our research group has previously developed internet-delivered CBT (Internet-CBT) targeting anxiety in asthma for adults, yielding promising results. Internet-CBT can significantly improve access to treatment and has been shown to be both effective and safe for other medical conditions. The primary aim of this project is to investigate whether Internet-CBT can contribute to improved quality of life, better asthma control, and reduced anxiety in children and adolescents whose asthma is complicated by their own or their parents' anxiety. We have previously developed Internet-CBT for adults with asthma and anxiety with promising outcomes. For this study, we have adapted the treatment for children, adolescents, and their parents and will evaluate its feasibility and clinical effectiveness.
- Status (registry)
- Active, not recruiting
- Study type
- Interventional
- Enrollment
- 30 (estimated)
- First submitted
- 3 Oct 2024
- Start date
- 1 Dec 2024
- Primary completion date
- Dec 2026
- Lead sponsor
- Karolinska Institutet
- Diseases
- Asthma
- NCT number
- NCT06657807
What you commit to
- Study type: Interventional
- Planned participants: 30
- From 1 Dec 2024 to the primary completion date, Dec 2026
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Concurrent psychological treatment
- Psychotropic medication should be stable for at least 1 month before entering the study.
Other illness
- Presence of severe psychiatric disorders such as severe depression or suicidal ideation.
- Presence of severe somatic disorder that could interfere with participation in the CBT-treatment
- Other respiratory disease than asthma
Who the study is looking for
- Age 8-17 years
- A diagnosis of asthma made by a physician and confirmed by the parents
- Some anxiety related to asthma reported by either parent of child ("Do you feel stressed or worried about your asthma?" yes/no) and/or some restriction by asthma in daily life, which could indicate a pattern of avoidance behavior ("Do you feel hindered by your asthma in your daily life?" yes/no)
Age in the registry: 8 years to 17 years · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Centre for Psychiatry Research, Karolinska Institutet & Stockholm Health Care Coordinator of this site? Confirm its status | Stockholm | Sweden | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.